Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q3 2019 · 10-Q
Revenue$2.21B$2.21B+3.4% vs Q3 2018 Net Income-$48.00M-$48.00MN/M vs Q3 2018 EPS Diluted-$0.14-$0.14N/M vs Q3 2018 Operating Income$329,000,000+181.2% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$432,000,000−11.8% Margins · derivedOperating margin14.9%+9.4 pt vs Q3 2018
Net margin-2.2%+14.3 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 4, 2019 · 35 d after period end